Carbohydrate microarray technologies are new developments at the frontier of glycomics that are showing great promise as tools for high-throughput analysis of carbohydrate-mediated interactions and the elucidation of carbohydrate ligands involved not only in endogenous receptor systems, but also pathogen-host interactions. The main advantage of microarray analysis is that a broad range of glycan sequences can be immobilized on solid matrices as minute spots and simultaneously interrogated. Different methodologies have emerged for constructing carbohydrate microarrays. The NGL (neoglycolipid)-based oligosaccharide microarray platform is among the relatively few systems that are beyond proof-of-concept and have provided new biological information. In the present article, I dwell, in some detail, on the NGLbased microarray. Highlights are the recent applications of NGL-based microarrays that have contributed to knowledge on the molecular basis of pathogen-host interactions, namely the assignments of the carbohydrate-binding specificities of several key surface-adhesive proteins of Toxoplasma gondii and other apicomplexan parasites, and the elucidation of receptor-binding specificities of the pandemic influenza A (H1N1) 2009 (H1N1pdm) virus compared with seasonal H1N1 virus.
Introduction
Carbohydrates are a class of highly complex and diverse biomolecules that are ubiquitous at cell surfaces of almost all organisms, and are also found in secretions and extracellular matrices. There is increasing awareness of the importance of carbohydrate chains (glycans or oligosaccharides), as posttranslational modifications of proteins and components of glycolipids and polysaccharides, in mediating diverse molecular interactions in health and disease processes, including those in infections, inflammatory reactions, immune responses and cancer [1, 2] . These are often through their interactions with specific binding proteins not only of endogenous receptor systems, but also those involved in pathogen-host interactions. For example, carbohydrate-protein interactions are known to be crucial at the initial stages of infections, namely the attachment of pathogens to host cells. These interactions often involve the proteins of pathogens binding to carbohydrate chains on the surface of host cells. The binding of carbohydrate chains on pathogen surfaces by host proteins can on the one hand be the route for infection, and on the other can lead to the innate and adaptive immunity against infection. The detailed analyses of these carbohydratemediated interactions have been among the most challenging areas in biology and medicine. This is mainly due to the difficulty in accessing the required amounts of complex and sequence-defined oligosaccharides (either by isolation from natural sources or by chemical synthesis), as well as the generally low affinity of most carbohydrate-protein interactions.
Since their advent in 2002 [3] [4] [5] [6] [7] , microarray technologies for carbohydrates have become powerful tools in glycobiology. Numerous glycans are immobilized as minute spots on matrices in the same manner, and tested simultaneously for binding by proteins and also microbes. This is revolutionizing studies of carbohydrate-protein interactions and the elucidation of carbohydrate ligands involved in biomedically important recognition events. Apart from the highthroughput feature of carbohydrate microarrays, the miniaturization allows for making the most of the precious materials of both carbohydrates and protein (or microbe) analytes. This is an advantage compared with traditional methods, such as ELISA, isothermal calorimetry and NMR.
A number of platforms have been described based on different methodologies for constructing carbohydrate microarrays [8] [9] [10] [11] [12] . In addition to conventional fluorescence detection of binding to microarrays, SPR (surface plasmon resonance) and MS have emerged as alternative means for measuring protein binding and determining glycoenzyme specificities [12] [13] [14] . The applications of different carbohydrate microarray platforms have been covered in some depth in previous reviews [15] [16] [17] [18] . The present review focuses on the NGL (neoglycolipid)-based oligosaccharide microarray system with which I have first-hand experience.
NGL-based oligosaccharide microarrays
The NGL technology, first introduced by Feizi and coworkers in 1985 [19] , is a unique and well-validated system that is coupled with MS and has led to the elucidation of numerous carbohydrate-recognition systems and discoveries of unsuspected oligosaccharide sequences on glycoproteins, as well as new oligosaccharide ligands for carbohydrate-binding proteins [20, 21] . NGL probes (generated by conjugation of free oligosaccharides to lipid tags) have several key features that render them ideal for microarrays [2] . First, the microscale lipid conjugation procedures, reductive amination [21] or oxime ligation [22] , allow easy access to diverse oligosaccharides isolated from natural sources that are only available in minute amounts and are difficult to synthesize chemically. This makes provision for generating 'designer' microarrays from targeted tissues and macromolecules. In addition, synthetic oligosaccharides and glycolipids, in particular those carrying unnatural modifications, have a place in screening studies in parallel with oligosaccharides derived from natural sources. These unnatural sequences are of interest as targets for the design of glycan-based drugs. Secondly, the amphipathic property conferred by the lipid tag enables efficient immobilization of NGLs in an orientated and clustered display on solid matrices, such as plastic, silica or nitrocellulose, for probing with various carbohydrate-recognizing systems, including antibodies and other effector proteins of the immune system, as well as pathogens or their adhesion proteins. In contrast with the covalently immobilized oligosaccharides which are fixed on the array surfaces, the non-covalently immobilized lipidlinked probes have potential lateral mobility and thus mimic the arrangement of clustered oligosaccharide structures at the surface of cells. This is important for many biologicalrecognition systems. A special feature of NGL technology is that highly heterogeneous mixtures of oligosaccharides when converted into NGLs can be resolved by high-performance TLC, probed for binding and the bound components sequenced by MS. This approach has proven to be a powerful means of discovering novel carbohydrate ligands.
With the use of high-precision robotic arraying hardware and high-resolution imaging, the NGL principle is now the basis of an advanced carbohydrate microarray system. It currently encompasses more than 600 lipid-linked oligosaccharide probes, which are printed on nitrocellulose-coated glass slides at low femtomolar levels ( Figure 1 ). The repertoire of probes include NGLs derived from diverse oligosaccharide sequences of mammalian-type glycoproteins, glycolipids and glycosaminoglycans, and those from bacterial, fungal and plant polysaccharides. Natural and synthetic glycolipids are also arrayed in parallel. The repertoire is continually expanding in number and structural diversity.
Considerable amounts of data are arising from highthroughput microarray experiments. The development and the use of software tools for storing, processing, displaying and interpreting carbohydrate microarray data became important from the outset. Thus a software tool for the NGL-based platform has been recently designed [23] . Notable among the recent contributions of NGL-based microarrays to the understanding of the biological systems that operate through carbohydrate recognition are: (i) the assignment of the ligands for a key receptor of the innate immune system against fungal pathogens, Dectin-1 [24] ; (ii) the demonstration of sulfation as a modulator of carbohydrate recognition by sialic-acid-binding receptors of the immune system known as siglecs (sialic acid-binding, immunoglobulin-like lectins) [25] and further information on the binding specificities of siglecs toward modified forms of sialic acid [22] ; (iii) the discovery of the N-glycolyl analogue of ganglioside G M1 (which humans do not synthesize) as the preferred host-cell receptor for SV40 (simian virus 40) [26] , which may explain the high susceptibility of simians to this pathogen; and (iv) the clinching of the ligand for a novel protein in the endoplasmic reticulum, malectin [27] , leading to it being a candidate new player in the early steps of protein N-glycosylation, folding and quality control.
I describe below two other recent applications of the NGL-based microarray system in studies of the molecular basis of pathogen-host interactions.
Adhesive proteins of Toxoplasma gondii and other apicomplexan parasites
The family of apicomplexan parasites contain some of the most widespread protozoan parasites of humans and animals. Among these are the Plasmodium spp. causing malaria, Eimeria spp. responsible for coccidiosis in poultry, Neospora spp. causing neosporosis in cattle and Toxoplasma, the causative agent of toxoplasmosis in warm-blooded animals and humans. Unlike bacteria and viruses, T. gondii and other parasites of the apicomplexan family actively invade host cells and this process critically depends on MICs (micronemal proteins), which are released on to the parasite surface just before invasion of host cells and play important roles in host cell recognition, attachment and penetration [28] . Using structural studies, Blumenschein et al. [29] identified a novel cell-binding domain called the MAR (microneme adhesive repeat) at the N-terminal region of a key MIC of T. gondii termed TgMIC1-MARR. The natural ligands for TgMIC1 were unknown until the NGL-based microarray analyses of recombinant TgMIC1-MARR that revealed it recognizes a wide range of sialyl oligosaccharide sequences found on glycoproteins and glycolipids that are ubiquitous on the cell surface [29] . This led to cell-invasion studies that corroborated the importance of sialic acid, as well as the characterization of a critical threonine residue in the MAR domain which makes major contacts with the carboxy group of the sialic acid moiety [29, 30] . Thus an explanation was provided for the extremely broad range of cell types in humans and virtually all warm-blooded animals that can be infected by the parasite.
Following this observation and using BLAST searches, a whole family of MAR-containing proteins has been identified in enteroparasitic coccidians, a subclass of apicomplexans, including T. gondii, Eimeria spp. and Neospora spp. [31] . Moreover, many of these proteins possess the critical threonine-containing motif, a signature for sialic-acidbinding properties, and thus suggesting that all of these parasites exploit sialylated glycoconjugates on host cells as determinants for enteric invasion. Among the new proteins identified is a sialic-acid-binding lectin of T. gondii, MIC13. The NGL-based microarray analyses showed that TgMIC13, TgMIC1 and its homologue N. caninum MIC1 share a common preference for α2,3-over α2,6-linked sialyl oligosaccharide sequences. Interestingly, the three lectins have differing binding patterns (Figure 2 ). Consistent with previous findings [29] , TgMIC1 bound to a broad range of sialylated probes, the preferred ligands being α2,3-linked sialyl-N-acetyllactosamine sequences with or without fucosylation/sulfation on the N-acetylglucosamine residue. Most intense binding of TgMIC13 was observed to a glycan sequence having an unusual α2,9 sialyl linkage. This sequence was reported previously as a component on a murine neuroblastoma cell line [32] and a human embryonal carcinoma cell line [33] . The preferential binding of N. caninum MIC1 to the Table I in [31] . The binding signal for probe 88 was extremely high (saturated) and could not be accurately quantified (asterisk in B). Reprinted from [31] with permission.
6-sulfo-sialyl-Lewis
x sequence was also observed [31] . These findings, corroborated by structural considerations, may have implications for tissue tropism, which we are following up.
Receptor typing of H1N1pdm [pandemic influenza A (H1N1) 2009] virus
Since it first emerged in North America in mid-February 2009, the novel influenza A (H1N1) virus spread to most other regions of the world, causing the WHO (World Health Organization) to declare an emergent pandemic. Despite the generally mild nature of most infections, people infected with H1N1pdm are more likely to suffer more severe symptoms than those infected with the seasonal strain of H1N1. This has been corroborated by the greater virulence of the H1N1pdm virus in animal models compared with seasonal influenza viruses. The results are presented as a 'matrix' [23] showing the relative binding intensities, which were calculated as the percentage of the fluorescence signal intensity at 5 fmol given by the probe most strongly bound by each virus. Position denotes the probe position in the microarray. The list of probe designations, sequences and fluorescent binding intensities are as described in Supplementary Table 1 in [35] . The probes are grouped according to the sialic acid linkage in their termini. Reprinted from [35] with permission.
Receptor binding by the influenza virus HA (haemagglutinin), the initial event in virus infection, is known to be a major determinant of virus transmissibility and pathogenicity [34] . Human influenza viruses preferentially bind to oligosaccharide sequences (popularly referred to as 'receptors') terminating in α2,6-linked sialic acid, which predominate on epithelial cells of the upper respiratory tract of humans. This contrasts with avian influenza viruses (e.g. H5N1) which bind preferentially to sialyl α2,3-terminating oligosaccharides that predominate on the intestinal epithelial cells of birds and the lower respiratory tract of humans.
The first report relating to the glycan-binding properties of HA of H1N1pdm virus was a prediction based on structural modelling of the HA-receptor-binding site of H1N1pdm virus A/Cal/09 (California/4/2009) by Sasisekharan and co-workers [35] . The authors predicted that Cal/09 would be able to make optimal contacts with α2,6-linked sialyl glycans, a feature shared with other human H1N1 HAs and, in addition, make contacts with α2,3-linked sialyl glycans. However, in a follow-up study [36] , members of the same group examined binding of recombinant HA of Cal/09 to biotinylated sialyl glycan probes immobilized on streptavidin-coated plates and could detect binding to α2,6-linked sialyl poly-N-acetyllactosamine-based sequences, but not to the α2,3-linked sialyl analogues.
At about the same time, we carried out the first detailed microarray analyses of receptor binding by whole influenza viruses of H1N1pdm (inactivated) using the NGL-based analysis system and 80 sialyl-terminating oligosaccharide probes with differing backbone types, chain lengths and branching patterns, as well as various sialylation, fucosylation and sulfation patterns, representative of N-and O-glycans and glycolipids [37] . Among the viruses analysed were two H1N1pdm viruses Cal/09 and Ham/09 (A/Hamburg/5/2009) and a seasonal H1N1 virus Mem/96 (A/Memphis/14/96-M). The results clearly showed distinctive receptor-binding profiles of the H1N1pdm viruses compared with that of seasonal influenza virus (Figure 3 ). Unlike the seasonal H1N1 influenza virus that bound exclusively to α2, 6- Thus the receptor-binding studies using the NGL-based microarrays which mimic the glycan presentation at the cell surface have provided evidence for the ability of the H1N1pdm virus to bind to the sialyl α2,3 in addition to α2,6 receptors. This broader specificity may account, at least in part, for the capacity of the pandemic virus to cause more severe and fatal disease in humans than observed with seasonal influenza. This work is currently being followed up by receptor-binding studies of H1N1pdm viruses isolated from fatal cases that bear various HA mutation sites.
Conclusions and future prospects
Carbohydrate microarrays are coming of age as powerful tools not only in glycobiology, but are also impinging on other disciplines, including chemistry, molecular and cell biology, microbiology, immunology and others. The ability to rapidly enlarge glycan libraries by incorporating both natural and synthetic oligosaccharides, and the clustered and flexible presentation of non-covalently immobilized lipid-linked probes with an element of mobility, are the two key advantages of the NGL-based microarrays that render the system powerful in providing information on the molecular basis of both endogenous receptors and pathogenhost interactions. Although microarrays of sequence-defined glycan probes are of proven value for analysing pathogenhost interactions, a key question remaining to be answered is: what are the 'real' carbohydrate receptors within the diverse epithelial glycan populations for influenza viruses and other pathogens? To address this, there is a need to develop and apply carbohydrate microarrays to explore glycomes in order to identify the ligand(s) in biologically relevant sources for each carbohydrate-recognition system. There have been initial efforts in this direction [24, 38] , and undoubtedly we will witness further innovation in the technologies. Success in this further development would not only advance our understanding of the pathobiology of infection, but also could potentially be exploited in pharmaceutical intervention, e.g. carbohydrate-based anti-adhesion drugs and virus receptor typing kits for clinical usage.
